Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1106 | 962 | 1138 | 1032 | 1393 | 2259 |
Fund Return | 10.59% | -3.76% | 13.8% | 1.04% | 6.86% | 8.49% |
Place in category | 90 | 213 | 113 | 147 | 109 | 38 |
% in Category | 13 | 37 | 19 | 36 | 35 | 14 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
JPM Global Income A acc EUR | 17.94B | 8.01 | 0.19 | 2.14 | ||
LU0740858492 | 17.94B | 7.65 | -0.16 | 1.78 | ||
JPMorgan Global Income A Div EUR | 17.94B | 8.00 | 0.19 | 2.14 | ||
JPM Global Income Fund A Mth EUR | 17.94B | 8.00 | 0.18 | - | ||
JPMorgan Global Income D div EUR | 17.94B | 7.67 | -0.16 | 1.79 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Allianz Europe Equity Growth A EUR | 3.21B | 0.14 | -4.83 | 6.54 | ||
Allianz Europe Equity Growth AT EUR | 3.21B | 0.14 | -4.83 | 6.53 | ||
Allianz Europe Equity Growth P EUR | 3.21B | 0.93 | -4.02 | 7.45 | ||
Allianz Europe Equity Growth I EUR | 3.21B | 0.97 | -3.98 | 7.49 | ||
Allianz Europe Equity Growth PT EUR | 3.21B | 0.93 | -4.02 | 7.44 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.26 | 635.9 | +2.14% | |
SAP | DE0007164600 | 5.07 | 239.500 | +1.33% | |
ASML Holding | NL0010273215 | 3.59 | 684.90 | -0.52% | |
Schneider Electric | FR0000121972 | 2.94 | 241.05 | +0.52% | |
AstraZeneca | GB0009895292 | 2.33 | 10,460.0 | +0.23% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | Strong Buy |
Summary | Strong Sell | Strong Sell | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review